CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-10-06 | Conti Kurt G Director | Conversion | +163,731 | 324,541 | ||
| 2015-10-06 | Conti Kurt G Director | Conversion | +29,238 | 29,238 | ||
| 2015-10-06 | Conti Kurt G Director | Conversion | +14,619 | 14,619 | ||
| 2015-10-06 | Conti Kurt G Director | Conversion | +14,619 | 14,619 | ||
| 2015-10-06 | Conti Kurt G Director | Conversion | +789,420 | 789,420 | ||
| 2015-10-06 | Conti Kurt G Director | Conversion · Series A Convertible Preferred Stock | −220,000 | 0 | ||
| 2015-10-06 | Conti Kurt G Director | Conversion · Series B Convertible Preferred Stock | −224,000 | 0 | ||
| 2015-10-06 | Conti Kurt G Director | Conversion · Series B Convertible Preferred Stock | −40,000 | 0 | ||
| 2015-10-06 | Conti Kurt G Director | Conversion · Series B Convertible Preferred Stock | −20,000 | 0 | ||
| 2015-10-06 | Conti Kurt G Director | Conversion · Series B Convertible Preferred Stock | −20,000 | 0 | ||
| 2015-10-06 | Conti Kurt G Director | Conversion · Series B Convertible Preferred Stock | −1,080,000 | 0 | ||
| 2015-10-06 | BARER SOL J Director | Conversion | +350,852 | 350,852 | ||
| 2015-10-06 | BARER SOL J Director | Conversion | +83,536 | 434,388 | ||
| 2015-10-06 | BARER SOL J Director | Conversion | +48,103 | 482,491 | ||
| 2015-10-06 | BARER SOL J Director | Conversion | +105,319 | 587,810 | ||
| 2015-10-06 | BARER SOL J Director | Purchase | +45,000 | $11.00 | $495K | 632,810 |
| 2015-10-06 | BARER SOL J Director | Other acquisition | +12,735 | $6.17 | $79K | 645,545 |
| 2015-10-06 | BARER SOL J Director | Conversion · Series B Convertible Preferred Stock | −480,000 | 0 | ||
| 2015-10-06 | BARER SOL J Director | Conversion · Series B-1 Convertible Preferred Stock | −114,285 | 0 | ||
| 2015-10-06 | BARER SOL J Director | Conversion · Series C Convertible Preferred Stock | −65,809 | 0 |
Page 15 of 18 · 346 trades